&nbsp;

Aug 2025

Drug

teclistamab

Other Name(s): Tecvayli®

Quick Link(s):

Jul 2025

Drug

glofitamab

Other Name(s): Columvi®

Quick Link(s):

Updated

Aug 2025

Regimen

GLOF; GLOF(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

High Cost Therapy Funding Program

Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

, Collapse Show fewer tags

Drugs Used:

oBINutuzumab,

glofitamab

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

TEBE; TEBE(RAMP)

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Tebentafusp (Outpatient) - Unresectable or Metastatic Uveal Melanoma

High Cost Therapy Funding Program

Tebentafusp (Inpatient) - Unresectable or Metastatic Uveal Melanoma

, Collapse Show fewer tags

Drugs Used:

tebentafusp

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

EPCO; EPCO(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Epcoritamab (Outpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

High Cost Therapy Funding Program

Epcoritamab (Inpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

, Collapse Show fewer tags

Drugs Used:

epcoritamab

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2025

Drug

epcoritamab

Other Name(s): Epkinly™

Quick Link(s):

Updated

Aug 2025

Drug

tebentafusp

Other Name(s): Kimmtrak®

Quick Link(s):